Thus, we comprehensively investigated the expression and efficacy of KDM1A on a total of 33 different cancer types in TCGA, GTEx, and CPTAC databases from the following aspects including gene expression, mutations, protein phosphorylation, DNA methylation, and tumor-infiltrating immune. The gene discussed is KDM1A; the disease is cancer.